Andrographolide (a terpenoid) inhibits NSCLC tumor growth by inhibiting the phosphorylation of STAT3 and p62 accumulation, regulating selective autophagic degradation of PD-L1, and increasing the infiltration and function of CD8+ T cells [88]. Here, CD8A is linked to neoplasm.